Status:
TERMINATED
A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment
Lead Sponsor:
Barwon Health
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
This is a pilot study assessing the role of the general practitioner in performing follow-up reviews on men who have recently completed radical radiotherapy for prostate cancer. This will be measured ...
Eligibility Criteria
Inclusion
- Men with a tumour T1-3 stage prostate cancer and have had radical radiotherapy with curative intent
- Are between six and twelve months post-treatment completion
- Have completed all treatment for prostate cancer (including hormonal deprivation therapy)
- Have no evidence of metastatic disease
- ECOG performance status of between 0-1
- Remains willing to comply with study requirements
- Has maintained contact with an individual general practitioner
Exclusion
- Persistent complications resulting from treatment defined as a minimum Grade 3 treatment toxicity
- Unable to complete self-administered questionnaires
- Are currently enrolled in a study that requires specialist follow-up
- Life expectancy of less than 6 months
- Surgery to remove the prostate
- Evidence of biochemical failure
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT00823771
Start Date
October 1 2007
End Date
April 1 2014
Last Update
February 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andrew Love Cancer Centre
Geelong, Victoria, Australia, 3220